Docu Liquid

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Docu Liquid
Generic name
DOCUSATE SODIUM
Manufacturer
ATLANTIC BIOLOGICALS CORP.
Product type
HUMAN OTC DRUG
SPL set ID
f4ed0721-3be9-4108-a6c9-dbbe115249e9
SPL ID
3b3f3045-55db-5ed5-e063-6294a90aab75
Version
3
Effective date
2025-07-31
Source export date
2026-11-06
Source partition
3
Source file
https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/97001096994db9ca8cee114e6c3bb5298d3c573158ffc1ab8692d82e76a3eb40/drug-label-0003-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 06:55:07
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do Not Use if you are presently taking mineral oil when abdominal pain, nausea, or vomiting are present for longer than one week Ask a doctor before use if you have noticed a sudden change in bowel habits that lasts over two weeks. Ask a doctor or pharmacist before use if you are taking any other drug. Take this product two or more hours before or after other drugs. Laxatives may affect how other drugs work. Stop use and ask a doctor if you have rectal bleeding you fail to have a bowel movement after use of this product These may indicate a serious condition. If pregnant or breast-feeding, ask a health professional before use. Keep Out of Reach of Children In case of overdose, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.